TeleDaaS Launches as Premier Provider of Dosimetry as a Service for Clinical Research Organizations
Imaging Technology
NOVEMBER 26, 2023
"We are launching TeleDaaS today to arm those researching and developing breakthrough cancer treatments with the technology and services needed to usher in the next generation of precision cancer therapies,” said TeleDaaS Chief Medical Officer Dr. Mark Crockett, M.D. TeleDaaS licenses a cloud-based technology platform from Mirada Medical.
54 
Let's personalize your content